AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2014

May 8, 2014

32414_dirs_2014-05-08_a3e0a804-91e8-4cc5-ac9f-891074741ae5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-05-06

Reporting Person: Gold Mark Stephen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-06	Common Stock	P	490	$2.60	Acquired	270484	Direct
2014-05-07	Common Stock	P	1487	$2.60	Acquired	271971	Direct

Footnotes

F1: Acquired in open market transaction.

F2: These shares include 144,471 shares held jointly by Dr. Gold and his wife and 126,013 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.

F3: These shares include 144,471 shares held jointly by Dr. Gold and his wife and 127,500 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.